The Women’s Tennis Association (WTA) has announced a groundbreaking program to provide paid maternity leave for players on the tour. With support from Saudi Arabia’s sovereign wealth fund (PIF), athletes will be able to receive up to 12 months of paid leave, along with access to infertility treatments such as egg freezing and in vitro fertilization. This program, which will benefit more than 320 players, is the first of its kind in women’s sports and aims to balance athletic careers with family aspirations.

The initiative has been well received by prominent tennis figures, including Victoria Azarenka, who emphasized the importance of this support for players seeking to combine their careers with motherhood. While Saudi Arabia has faced criticism for its policies on women’s rights, its investment in women’s tennis has been significant, including hosting the WTA Finals in Riyadh starting in 2024.

A MAJOR STEP FOR WOMEN’S SPORTS

The WTA’s maternity leave program represents a significant advancement in gender equality in professional sports. By offering financial support and flexibility to players who become mothers, the WTA seeks to ease the pressure on athletes who must choose between their careers and their families. Such initiatives not only benefit current players but can also inspire future generations to pursue their athletic dreams without sacrificing their personal aspirations.

The collaboration between the WTA and PIF also reflects a shift in the perception of women’s sports, where athletes no longer have to face the challenges of motherhood alone. With this program, the WTA becomes a pioneer in supporting mothers in professional sports, setting a precedent that could influence other sports disciplines. Additionally, the inclusion of infertility treatments broadens the program’s reach, providing additional options for players looking to plan their families.